Epidemiology of Neonatal Hyperbilirubinemia in Niamey: about 146 Cases Collected at Issaka Gazobi Maternity Hospital

International Journal of Biotech Trends and Technology (IJBTT)
© 2018 by IJBTT Journal
Volume - 8 Issue - 2                          
Year of Publication : 2018
Authors : Mounkaila B, Oumarou Z, Farya Toukoua O, Hassane M
DOI :  10.14445/22490183/IJBTT-V8I2P603


Mounkaila B, Oumarou Z, Farya Toukoua O, Hassane M "Epidemiology of Neonatal Hyperbilirubinemia in Niamey: about 146 Cases Collected at Issaka Gazobi Maternity Hospital", International Journal of Biotech Trends and Technology (IJBTT), V8(2): 13-17 April - June 2018, Published by Seventh Sense Research Group.


Neonatal hyperbilirubinemia is a major morbidity and mortality factor, especially in a context of early exit of newborns. This study is aimed at determining the frequency of this pathology and characterizing its epidemiological aspects in the Neonatology Department at Issaka Gazobi Maternity Hospital in Niamey. This is a descriptive and cross-sectional monocentric study, expanding over 5 months in the Neonatology Department. It involved newborns with local or generalized jaundice and hospitalized in the Neonatal Department. The frequency of neonatal jaundice was 19.5%, with a gender ratio of 1.92. On average, mothers were aged 26.4 ± 4.2 years and almost half (46.4%) of them were under 25 years old. 64.3% were term births against 35.7% of preterm births. This was due to prophylactic caesarean section (32.3%), premature membrane rupture (17.7%), fetal suffering and severe pre-eclampsia 11.8% respectively. Etiologies of these jaundices were dominated by infections (39%), neonatal malaria (17.1%) and fetal-maternal incompatibility in the ABO/Rh system (15.7%). Development was good in 69.65% of cases against 10.7% of deaths. Infections, neonatal malaria and maternal-fetal incompatibility are the main etiologies of neonatal hyperbilirubinemia in Niamey. Mortality rate related to this pathology is very high.


[1] Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights. Pediatric Clinics of North America. 2009; 56, 671–687.
[2] Watchko JF. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clinics in Perinatology 2006; 33: 839-52;
[3] Hameed NN, Na?Ma AM, Vilms R and Bhutani VK. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 2011; 100:57-63
[4] Olusanya BO, Akande A, Emokpae A and Olowe SA. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Tropical Medicine and International Health. 2009; (14):301-10
[5] Phyllis A Dennery, DanieL S. Seidman, and David K. Stevenson. Neonatal hyperbilirubinemia. New England Journal of Medecine 2001;344(8)
[6] Scrafford CG, Mullany LC, Katz J, Khatry SK, LeClerq SC, Darmstadt GL and Tielsch JM. Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal. Tropical Medicine and International Health, 2013;18(11): 1317-28
[7] Mutombo AK, Mukuku O, Kabulo BK, Mutombo AM, Ngeleka AM, Mutombo JD et al Ictères pathologiques du nouveau né à l?hôpital Bonzola de Mbuji-Mayi, République Démocratique du Congo. Pan African Medical Journal. 2014;19:302
[8] Rasul CH, Hasan A, Yasmin F. Outcome of Neonatal Hyperbilirubinemia in a Tertiary Care Hospital in Bangladesh. Malaysian Journal of Medical Sciences. 2010; 17(2): 40-44.
[9] Sarici SU, Serdar MA, Korkmaz A et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics. 2004; 113: 775–780.
[10] Tioseco JA, Aly H, Milner J, Patel K, El-Mohandes AA. Does gender affect neonatal hyperbilirubinemia in low-birth-weight infants? Pediatric Critical Care Medicine 2005; 6:171-4
[11] Alkhotani A, Eldin EEMN, Zaghloul A, Mujahid S. Evaluation of neonatal jaundice in the Makkah region. Scientific Reports. 2014; 4: 4802
[12] Esfandiarpour B, Ebrahimi H, Karkan MF, Farahmand N, Karambin MM. Neonatal exchange transfusion for hyperbilirubinemia in Guilan (the north province of Iran): a 3-year experience. Turkish Journal of Pediatrics. 2012; 54 (6): 626-631
[13] Kaplan M, Rubaltelli FF, Hammerman C, Vilei MT, Leiter C, Abramov A et al. Conjugated bilirubin in neonates with glucose -6-phosphate deshydrogenase deficiency. The Journal of Pediatrics. 1996, 128 (5):695-7
[14] Singh K, Singh P, Sagar M, Mehra V,Neki NS. Incidence, etiological risk factors and outcome of glucose-6 phosphate dehydrogenase deficiency (G6PD) among neonates presenting with hyperbilirubinemia in tertiary care hospital, Punjab. International Journal of Current Research in Medical Sciences. 2017; 3(3):62-71.
[15] Sinha R, Sachendra B, Syed VS, Nair L, John BM. To study the prevalence of glucose 6 phosphate dehydrogenase(G6PD) deficiency in neonates with neonatal hyperbilirubinemia and to compare the course of the neonatal jaundice in deficient versus non deficient neonates. Journal of Clinical Neonatology. 2017; 6: 71-4
[16] Daouda A, Mounkaila B, Maïguizo S, Moumouni Sina A, Sanogo I. G6PD deficiency: Study among 256 blood donors recruited at the blood transfusion center in Niamey. International Journal of Biotech Trends and Technology (IJBTT). 2016;16(1): 1-4
[17] Mounkaila B, Daouda A, Garba RM, Aridouane D. Neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency in Niamey. International Journal of Biotech Trends and Technology (IJBTT). 2016; 13(1): 12-14
[18] Surana AU, Patel S, Prasad R, Tilwani S, Saiyad A, Rathod M. Comparison of transcutaneous bilirubin with serum bilirubin measurements in neonates at tertiary care center in western part of india. International Journal of Contemporary Pediatrics. 2017; 4:1445-9.
[19] Isa HM, Mohamed MS, Mohamed AM, Abdulla A, Abdulla F. Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency. Korean Journal of Pediatrics. 2017; 60(4):106-11
[20] Aletayeb H, Mohammad S, Masoud D, Aramesh Reza M, Arash Malakian; Hedayati Zeinab; Taheri Mehri. Outcome of Jaundice in neonates with ABO and Rh blood incompatibility and glucose-6-phosphate dehydrogenase deficiency. Biomedical Research. 2017; 28(8):3440-44.

Hyperbilirubinemia, Neonates, Jaundice, Niamey.